Started my lab 2 years ago as an independent PI & had my share of doubts along the way but I’m starting to think that I’ll be OK 😁.
@PamSharmaMDPhD
. Thank you for all your support!!!
Some publications are extra special because of the emotional value attached to it. This project was developed when I first joined as an Assistant Professor and building my team. It has been through the difficult times during COVID. This paper is a testament to team science!
KDM6B-mediated reprogramming of myeloid cells regulates the response to immunotherapy | Nature Cancer
Thank you
@NatureCancer
for highlighting our recent publication with the accompanying Brief.
@MDAndersonNews
Some publications are extra special because of the emotional value attached to it. This project was developed when I first joined as an Assistant Professor and building my team. It has been through the difficult times during COVID. This paper is a testament to team science!
I was recently asked at a conference that as a physician-scientist how do I balance my clinic and lab team. My answer was “food”. Teams that eat together, stay together 😊. Goswami_Lab, Goswami_Clinic.
@MDAndersonNews
With super amazing
@CarolynBertozzi
. You are such a role model for generations of young scientists! It was a true honor to share the stage with you
@MDAndersonNews
#James
P Allison Institute.
It was fun sharing the podium with
@PavlosMsaouel
at MDACC Physician-scientist symposium on a Saturday morning!! Conclusions: 2 inch heels are not sufficient for me to be visible to audiences and I take better pictures than
@PavlosMsaouel
We spoke with Sangeeta Goswami, MD, PhD (
@SGoswamiMDPhD
), about her dynamic career path, the clinical trial work she leads related to immune checkpoint therapy, and the value she places on mentoring the next generation of women scientists. Read more:
2022 Leading Edge of Cancer Research symposium was started with the keynote address by Dr. Tyler Jacks. He’s the recipient of this years Ernst W. Bertner memorial award!
@MDAndersonNews
@ca_chung
@nadim_ajami
@LabJacks
, T Cascone, E Kelly, A Viale.
As a self-described “people person,” Dr. Sangeeta Goswami says her love of her patients and her colleagues fuels her work in both the clinic and the lab:
@SGoswamiMDPhD
#CancerResearch
#EndCancer
In addition to her work in the lab and treating patients with kidney or bladder cancer, our Dr. Sangeeta Goswami is mentoring the next generation of women in science, just as she was mentored by those who came before her:
@SGoswamiMDPhD
#EndCancer
Exciting new results presented at ESMO, from the first randomized trial proving benefit from targeting FGFR3: Erdafitinib treatment in Advanced or Metastatic Urothelial Carcinoma. Congratulations to Arlene Siefker-Radtke and collaborators.
Discover the
#SITC
Women in Cancer Immunotherapy Network (WIN) Leadership Institute program from the perspectives of previous attendees! Read their stories and insights firsthand and see the program's impact.
#WomenInSTEM
#testimonials
. Apply by April 3:
Kudos to our amazing students from University Outreach and Summer Undergraduate Research Programs who presented their posters at the 2022
@MDAndersonNews
Summer Experience Poster Session. Thank you faculty, staff and postdocs for your support.
@MelanconTess
@DianeBodurka
It’s such a moment of pride to see one of my close friends from medical oncology fellowship at MDACC, receiving distinguished alumni award at UT Christopher G. Wood Advances in Urologic Oncolgy at Austin.
@bilenma
@WinshipAtEmory
@MDAndersonNews
Amazing talk at Keystone meeting in Whistler by Dr. Sangeeta Goswami, revealing novel mechanisms of epigenetic regulation of CD8 T cell function linked to metabolic status.
@SGoswamiMDPhD
@MDAndersonNews
UT GSBS course on “ from bedside to bench and back”. Reverse translation strategy should lead the rational combination therapies in a tumor specific manner.
@PamSharmaMDPhD
@MDAndersonNews
Tremendously proud of Tina Cascone for her presentation at the 2023 ESMO meeting presidential session on the impact of neo adjuvant NIVO/chemo in respectable NSCLC.
Session I on Clonal expansion in normal and pathological tissues: it’s all a matter of fitness, Chaired by Andrea Viale. Fantastic talks and discussion.
@ca_chung
@nadim_ajami
, Tina Cascone
@MDAndersonNews
. Leading Edge of Cancer Research Symposium.
Session IV on clinical data science at the leading edge cancer research symposium. Chaired by
@ca_chung
. Fantastic discussion on artificial intelligence and it’s clinical utility.
@MDAndersonNews
Our very own AVPC guru giving an amazing talk on the emerging treatment landscape of aggressive variant prostate cancer at UT C. G Wood symposium!
@aaparicioMD
@ChapinMD
@MDAndersonNews
It was an wonderful experience having the career conversation about physician-scientist pathway in MD Anderson summer experience program for under graduate students. Motivating the next generation of physician-scientists!!!
@MelanconTess
@cbartholomeusz1
Hear how immunotherapy for kidney cancer is changing the outlook for patients from CRI Lloyd J. Old STAR Dr. Kissick
@EmoryUniversity
, former CLIP Investigator Dr. Goswami
@MDAndersonNews
and Peggy, a kidney cancer survivor, in
#KidneyCancerAwarenessMonth
:
It was an honor to chair the session II at the leading edge cancer symposium. 4 brilliant talks
@pbachi
@BettyKimLab
Yvonne Chen (UCLA) Saar Gil (UPenn). Great discussion on how to unleash the immune system!
@MDAndersonNews
Jim Allison pioneered the field of immunotherapy that provided durable clinical benefit including cure in a subset of cancer patients. Now, Allison institute will thrive to figure out how to extend the benefit to each and every patient.
@JimAllisonPhD
@PamSharmaMDPhD
#endcancer